Tazofelone

This classification denotes an immunosuppressant with the molecular formula C18H27NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) VH2I1JN8Q1, chemically known as 4-thiazolidinone, 5-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-, (+-)- but more generally known as tazofelone, which bears US NIH Compound Identifier 68745. European Medicines Agency schedules Tazofelone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10850MIG. The term TAZOFELONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). TAZOFELONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule tazofelone under HS 29341000 and SITC 51579. As of Q4 2014, TAZOFELONE remains US FDA's Preferred Term for this commodity. Tazofelone bears US NLM identifiers UMLS ID C0669581 and NCI Concept Code C76695. SMILES: S1C(CC2CC(C(C)(C)C)C(O)C(C(C)(C)C)C2)C(=O)NC1.